Professionals can also directly access courses from AAMDSIF at the Online Academy.
ONS Congress Satellite Symposium
The Spectrum of Bone Marrow Failure Diseases – Emerging Therapies and Precision Medicine Are Transforming Treatment
This symposium will be presented at the ONS Annual Congress in Washington, DC in May 2018, and is targeted to clinical nursing professionals in oncology. The program focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management and care coordination. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.
Thursday, May 17th
6:00 am – 7:30 am EST
Marriott Marquis – Marriott Marquis Ballroom 1 - 4
MDS Rounds: An AAMDSIF Visiting Faculty Program
The CME/CE-accredited MDS Rounds Program provides a forum for health care professionals who care for patients with bone marrow failure disorders to address issues related to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS). Participants will learn the latest information on new therapies and advances in the management of MDS through lecture and case studies developed and presented by an expert in hematology/oncology.
Designed for a standard one-hour program format, this program has been developed by the Aplastic Anemia and MDS International Foundation (AAMDSIF) and accredited by USF Health. It is available at no charge for medical centers to provide for their professional staff.
International Scientific Symposium 2018
March 22 – 23, 2018
AAMDSIF will sponsor its sixth International Bone Marrow Failure Disease Scientific Symposium on March 22-23, 2018, in Rockville, Maryland. The Symposium will bring together physicians treating these diseases; laboratory researchers studying the genetics, genomics, and pathophysiology of bone marrow failure; and clinical investigators to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field.
Regional Bone Marrow Failure Disease Symposia
Clinicians caring for both children and adults are frequently faced with patients with low blood counts and the challenge of initial management and work-up. This symposium will provide participants with the most up-to-date review of scientific and clinical research related to the biology and management of pediatric and adult bone marrow failure diseases, including anemia, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and paroxysmal nocturnal hemoglobinuria (PNH). The presenters will focus on the latest advances in the diagnosis, genetic characteristics, pathology and treatment options for these diseases, including the importance of recognizing adult presentations of inherited marrow failure syndromes and recent discoveries in inherited bone marrow failure defects.
- 2018 Fall dates to be announced soon
Recorded Education Programs
A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy
Friday, December 8, 2017 – 12:30-4:30 pm
Marriott Marquis Atlanta, Symposium Room A703 – A704
Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and the Aplastic Anemia and MDS International Foundation, preceding the 59th ASH Annual Meeting.
The complimentary symposium will provide an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The program will bring leaders in disease research and clinical practice together to explore solutions to improve the care of patients.
ONS Congress Satellite Symposium
Advances in Treating MDS and Related Bone Marrow Failure Diseases: The Role of Nurses in Managing Therapy and Personalizing Care
This breakfast symposium at the 2017 ONS Annual Congress focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management. Topics include the latest information on the pathophysiology and differential diagnosis of MDS and related bone marrow failure diseases, risk and prognostic scoring systems, treatment options for low-risk and high-risk MDS, AML, and MDS/MPN overlap, disease management, and ways to address psychosocial and quality-of-life issues to improve care of this patient population. Case studies will be used to illustrate diagnostic and therapeutic challenges.
Children and Adults with Severe Aplastic Anemia: Treatment Options, Care and Support
Sponsored jointly by the National Marrow Donor Program®/Be The Match® and the Aplastic Anemia and MDS International Foundation.
• Wednesday, March 29, 2017
• Watch the program.
In this free continuing education webinar a physician and social worker presented current research and case examples to illustrate treatment options and common experiences for patients with aplastic anemia and their families. The goal of this activity is to ensure that members of a multidisciplinary team have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with severe aplastic anemia.
Hematology, oncology and BMT nurses; hematology, oncology and BMT social workers at intermediate to advanced levels of practice, experience and licensure; transplant center coordinators; payer case managers and other allied health professionals.
David A Margolis, MD: Program Director, Bone Marrow Transplant, Children's Hospital of Wisconsin and Professor, The Medical College of Wisconsin
Sheila Dodds, MSW: Pediatric Social Worker, Bone Marrow Transplant Program, Children’s Hospital of Wisconsin
This program is accredited for nurses, social workers and medical technologists.
Clinical Management of MDS/MPN: A Mountain of Evidence for Treatment Selection in MDS/MPN
CME-certified Satellite Lunch Symposium, preceding the 58th ASH Annual Meeting
This webcast, recorded at our ASH 2016 Satellite Symposium, focuses on the biology, prognosis, natural history and therapeutic management of patients with MDS, MPN, and MDS/MPN overlap.
Treatment Decision-Making Through the Spectrum of MDS
Explaining MDS to patients can be challenging for healthcare professionals. The disease process is complex, the prognosis variable, and treatment options must be tailored for each patient. This series of three continuing education programs - one each for low risk MDS, high risk MDS, and stem cell transplantation - focuses on effective communication to ensure optimal outcomes when managing patients with MDS.
The target audience for these programs is oncologists, hematologists, oncology nurses, and other healthcare providers who diagnose and manage MDS patients.
Assessing Anemia in Older Patients and When to Suspect MDS
AA&MDSIF is committed to providing quality and timely educational activities for community hematologists/oncologists, gerontologists, and primary care physicians. This webcast is a studio-based discussion between an academic-based hematologist/oncologist specializing in MDS and a community-based oncologist. These two professionals discuss cases to review the evaluation and work-up of anemia and cytopenias seen in general practice and to review symptoms, clinical presentations, treatment options and post-diagnosis issues common within MDS.
B. Douglas Smith, MD, Professor of Oncology and Eric J. Seifter, MD, Associate Professor of Medicine and Oncology, Johns Hopkins University School of Medicine
Upon completion of this program, viewers will be able to
- Identify the symptoms that in conjunction with anemia, should lead to suspected MDS
- Discuss diagnostic techniques, including bone marrow biopsy
- Review treatment options for patients with MDS, including supportive care, and assistant in the development of appropriate treatment goals for MDS patients
- Understand how immunomodulatory drugs work against MDS
- Be familiar with benefits, safety margins, and adverse effects of medications used to treat MDS
Part 1: Diagnosing MDS
Part 2: MDS Diagnostic Workup, Staging and Supportive Therapy
Part 3: Beyond Supportive Therapies
International Scientific Symposium 2016
Global experts in bone marrow failure disease come to our signature event, the two-day International Scientific Symposium, to present and compare data in high-level sessions that help improve treatments, advance new research theories and foster collaboration. These events typically consist of 40+ presentations by the world's top researchers and medical experts. The Foundation then produces summaries of the scientific presentations in layman's language for distribution to our patients and families so that they also benefit from the exchange of information among leaders in the field of bone marrow failure. All AAMDSIF symposia earn exceptionally high marks from the health professionals who attend.
- The Genetics of Bone Marrow Failure
- Transplant Treatments for Bone Marrow Failure
- The Immunology of Bone Marrow Failure Disease
- Pathophysiology and New Molecular Targets of Bone Marrow Failure
- Non-Transplant Options for Aplastic Anemia and PNH
- Non-Transplant Treatment Options for MDS
- Transplant and Treatment for Older Patients with Aplastic Anemia
- Diagnosis of Bone Marrow Failure in the Genomics Era
- Cutting Edge Approaches to Treating Aplastic Anemia